Device Trial Radar · NCT00963742
Lenstec Softec HD Posterior Chamber Intraocular Lens Clinical Investigational Protocol
Last checked: Nov 20, 2026Latest source record: Mar 18, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
390
Actual
Start
Dec 2006
Primary completion
Jul 2009
Study completion Apr 2010
Sponsor
- Lead sponsor
- Lenstec IncorporatedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 21, 2009
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objectives of this multi-center clinical investigation are to determine the safety and effectiveness of the Lenstec Softec HD Posterior Chamber intraocular lens (IOL) following one year of post-operative assessment.
Conditions
- Cataract
Interventions
Lenstec Softec HD IOL implantationDevice
surgical removal of cataract and implantation of Softec HD PCIOL
Primary outcomes
What the sponsor says the trial is designed to measure.
- Distance Best Corrected Visual AcuityTime frame: 1 year
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.